DrugPatentWatch Database Preview
Details for Patent: 6,051,567
» See Plans and Pricing
Summary for Patent: 6,051,567
Title: | Low oxygen content compositions of 1.alpha., 25-dihydroxycholecalciferol |
Abstract: | The invention relates to stable aqueous formulations comprising 1.alpha., 25-dihydroxycholecalciferol, a unit dose system comprising the same in a sealed vessel, and a process for preparing them. |
Inventor(s): | Abrahamson; Kent (Libertyville, IL), Anderson; Amy N. (Waukegan, IL), Grady; Haiyan (Mundelein, IL) |
Assignee: | Abbott Laboratories (Abbott Park, IL) |
Application Number: | 09/365,533 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Composition; |
Drugs Protected by US Patent 6,051,567
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | CALCIJEX | calcitriol | INJECTABLE;INJECTION | 018874-001 | Sep 25, 1986 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | |||||
Abbvie | CALCIJEX | calcitriol | INJECTABLE;INJECTION | 018874-002 | Sep 25, 1986 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |